Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.
Cutiss has raised $38.9M in total funding. The most recent round was Series C. The last funding was announced in September 2025.
Cutiss's investors include Zürcher Kantonal Bank, Innosuisse, Swisspreneur Syndicate, Shiloh Advisors, Government of France.
Cutiss is headquartered in Zürich, Switzerland.
Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.
Cutiss is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cutiss — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/cutiss. Accessed August 23, 2026.
VCBacked. (2025). Cutiss — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/cutiss
{{cite web |title=Cutiss — Funding & Investors |url=https://www.vcbacked.co/company/cutiss |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated